IFR:李澤楷旗下的富衛集團在考慮於何地上市
彭博報道,IFR引述不具名人士消息報道,億萬富豪李澤楷旗下的富衛集團正在考慮去新加坡上市,或是與在一家美國上市收購公司合併,從而保持同股不同權架構。
在香港上市可能與預期的資本結構不符。
香港上市規則只允許創新類公司採取同股不同權架構。
富衛集團不完全符合香港交易所對創新類公司的定義, 目前正嘗試與交易所解決這一問題。
另外也在考慮赴美國上市;可能會以與特殊目的收購公司(SPAC)合併的形式上市。
關於富衛
據其公司官網介紹,富衛是盈科拓展集團旗下的保險業務,瑞士再保險、GIC Ventures、RRJ Capital 及 Hopu Investments 也分別是股東之一。公司在香港及澳門持續錄得穩健業績。富衛香港的人壽保險營運機構總資產爲143億美元,較去年同期上升15.8%(截至2019年12月31日)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.